Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Add-on Clioquinol in Drug-resistant Childhood Epilepsy: an Exploratory Study

NCT05727943 is registered in ClinicalTrials.gov with KU Leuven as lead sponsor.

NCT NCT05727943
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05727943 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Add-on Clioquinol in Drug-resistant Childhood Epilepsy: an Exploratory Study
Lead sponsor
KU Leuven
Phase
Phase 2
Overall status
Unknown status
Start date
March 1, 2022
Completion date
December 31, 2023
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy intractable